Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating maralixibat for progressive familial intrahepatic cholestasis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Familial Intrahepatic Cholestasis

Drugs mentioned

• Maralixibat (maralixibat)

Snippet

Sponsor: Mirum Pharmaceuticals, Inc. | Conditions: Progressive Familial Intrahepatic Cholestasis (PFIC) | Phase 3 | Status: COMPLETED | Results posted: 2023-12-11